CD 23 Expression in Plasma Cell Myeloma with t(11;14)

被引：0
|
作者：
Tawil, R. N.
Ahmed, Q.
Mohamed, A. N.
Bentely, G.
机构：
[1] Wayne State Univ, Sch Med, Detroit, MI USA
[2] Detroit Med Ctr, Detroit, MI USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1452
引用
收藏
页码：325A / 325A
页数：1
相关论文
共 50 条
  • [41] A rare case of multiple myeloma with double translocations: t(11;14) and t(14;16)
    Meseha, Mina
    Patel, Vishw
    Sekla, Kirolos
    Yang, Ping
    Coffey, David
    JOURNAL OF HEMATOPATHOLOGY, 2025, 18 (01)
  • [42] CD138- plasma cell myeloma
    Shuai, Wen
    Li, Shaoying
    BLOOD, 2019, 134 (11) : 906 - 906
  • [43] Clinical outcomes in t(11;14) multiple myeloma.
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Lacy, Martha
    Gertz, Morie A.
    Buadi, Francis
    Dingli, David
    Hayman, Suzanne R.
    Kapoor, Prashant
    Hwa, Yi Lisa
    Lust, John Anthony
    Go, Ronald S.
    Kyle, Robert A.
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Natural history of t(11;14) multiple myeloma (MM).
    Lakshman, Arjun
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Gertz, Morie A.
    Buadi, Francis
    Lacy, Martha
    Dingli, David
    Hayman, Suzanne R.
    Gonsalves, Wilson I.
    Kapoor, Prashant
    Leung, Nelson
    Lin, Yi
    Go, Ronald S.
    Kourelis, Taxiarchis
    Lust, John Anthony
    Russell, Stephen
    Zeldenrust, Steven R.
    Kyle, Robert A.
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Redefining the Prognostic Significance of t(11;14) Multiple Myeloma
    Bal, Susan
    Giri, Smith
    Godby, Kelly N.
    Costa, Luciano J.
    BLOOD, 2020, 136
  • [46] Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma
    Kraj, Maria
    Sokolowska, Urszula
    Kopec-Szlezak, Joanna
    Poglod, Ryszard
    Kruk, Barbara
    Wozniak, Jolanta
    Szpila, Tomasz
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 298 - 305
  • [47] CD3 expression in plasma cell neoplasm (multiple myeloma): a diagnostic pitfall
    Tang, Yee Lin
    Chau, Cora Yuk-Ping
    Yap, Wai Ming
    Chuah, Khoon Leong
    PATHOLOGY, 2012, 44 (07) : 668 - 670
  • [48] Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression
    Roy, Tina
    An, Joseph B.
    Doucette, Kimberly
    Chappell, Aimee M.
    Vesole, David H.
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 759 - 761
  • [49] Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14)
    Otsuki, T
    Wada, H
    Nakazawa, N
    Taniwaki, M
    Kouguchi, K
    Ohkura, M
    Uehira, K
    Isoda, K
    Yata, K
    Sakaguchi, H
    Yawata, Y
    Ueki, A
    Yamada, O
    LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 761 - +
  • [50] Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence
    Kitadate, Akihiro
    Terao, Toshiki
    Narita, Kentaro
    Ikeda, Sho
    Takahashi, Yuto
    Tsushima, Takafumi
    Miura, Daisuke
    Takeuchi, Masami
    Takahashi, Naoto
    Matsue, Kosei
    CANCER SCIENCE, 2021, 112 (09) : 3645 - 3654
12345